Shares of U.S. and Canadian cannabis stocks continued their rally on Tuesday, after President Donald Trump a day earlier said he was “very strongly” weighing an executive order to reschedule the drug — a move that would lift some regulations on the substance.

New research reveals significant gaps between public perception and scientific evidence for medical cannabis benefits across most health conditions.

President Trump is expected to sign an executive order as soon as this week that would fast-track the reclassification of cannabis. NBC News' Julie Tsirkin stopped by "Here's the Scoop" to talk about what that could mean for medical use.

The review also found that daily use of medical cannabis — especially inhaled or high-potency products — may increase the risk of cardiovascular problems compared with occasional use. That includes a higher chance of heart attack, stroke and coronary artery disease.

NEW YORK, NY / ACCESS Newswire / December 17, 2025 / The cannabis industry has evolved faster than the systems that support it. What began as a loosely regulated agricultural product has grown into a differentiated market spanning medical treatments,

A recent review published in JAMA found that the evidence to support the use of cannabis and cannabinoids for most medical indications is insufficient. The authors state that only specific pharmaceutical-grade cannabinoid products approved by the Food and Drug Administration (FDA) have demonstrated clear clinical benefits.

Canadian cannabis stocks, including Tilray (TLRY), surged following reports that President Donald Trump could sign an executive order as soon as Monday reclassifying marijuana from a Schedule I drug like heroin to the less-restrictive Schedule III category,

A multi-national medical supply company is expanding into Scotland with a cannabis manufacturing facility in the Borders. Breathe Life Sciences (BLS) will create 36 jobs when the production and distribution centre opens towards the end of next year - with a three year plan for the workforce to increase to around 100.

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana in 2026.

The most frequently reported reasons for medicinal cannabis use are for pain relief and improvements in sleep. Although cannabis is believed to have an interconnected role with both pain and sleep, its effects on chronic pain and sleep architecture have been studied largely in isolation.

Cannabis users are “greater danger” than alcohol users; Dems push legalization; Senate marijuana banking testimony Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning.